Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 29 04:00PM ET
17.41
Dollar change
-0.42
Percentage change
-2.36
%
Index- P/E4.36 EPS (ttm)3.99 Insider Own0.11% Shs Outstand255.63M Perf Week-6.15%
Market Cap4.45B Forward P/E3.88 EPS next Y4.48 Insider Trans0.98% Shs Float255.36M Perf Month3.75%
Income1.02B PEG- EPS next Q1.07 Inst Own78.83% Short Float5.22% Perf Quarter54.07%
Sales6.26B P/S0.71 EPS this Y4.02% Inst Trans-0.05% Short Ratio3.39 Perf Half Y-22.10%
Book/sh-0.27 P/B- EPS next Y4.12% ROA8.89% Short Interest13.34M Perf Year-28.91%
Cash/sh2.71 P/C6.42 EPS next 5Y-5.00% ROE- 52W Range10.84 - 24.99 Perf YTD20.74%
Dividend Est.1.11 (6.36%) P/FCF8.12 EPS past 5Y-14.04% ROI11.62% 52W High-30.33% Beta0.78
Dividend TTM1.12 (6.43%) Quick Ratio1.09 Sales past 5Y-7.62% Gross Margin59.84% 52W Low60.68% ATR (14)0.69
Dividend Ex-DateFeb 23, 2024 Current Ratio1.54 EPS Y/Y TTM10.96% Oper. Margin21.19% RSI (14)52.37 Volatility3.56% 3.77%
Employees10000 Debt/Eq- Sales Y/Y TTM1.44% Profit Margin16.33% Recom2.30 Target Price21.38
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q403.17% Payout28.06% Rel Volume0.71 Prev Close17.83
Sales Surprise2.83% EPS Surprise8.51% Sales Q/Q7.61% EarningsFeb 15 BMO Avg Volume3.94M Price17.41
SMA200.44% SMA508.16% SMA200-1.35% Trades Volume2,781,878 Change-2.36%
Date Action Analyst Rating Change Price Target Change
Nov-03-23Downgrade Goldman Buy → Neutral $33 → $16
Sep-21-23Initiated Barclays Overweight $28
Mar-16-23Initiated Raymond James Outperform $33
Oct-14-22Downgrade BofA Securities Neutral → Underperform $27 → $25
Sep-06-22Upgrade Piper Sandler Neutral → Overweight $37 → $34
Aug-05-22Downgrade BofA Securities Buy → Neutral $40 → $37
Apr-27-22Initiated Goldman Buy $40
Apr-06-22Resumed Morgan Stanley Equal-Weight $35
Oct-07-21Initiated Piper Sandler Neutral $35
Sep-01-21Initiated BofA Securities Buy $43
Feb-20-24 08:00AM
07:45AM
Feb-16-24 09:47AM
Feb-15-24 11:00AM
07:30AM
08:05AM Loading…
Feb-14-24 08:05AM
Feb-01-24 07:30AM
Jan-12-24 06:53AM
Jan-10-24 07:33AM
Jan-08-24 07:30AM
Dec-21-23 07:30AM
Dec-18-23 07:30AM
Nov-21-23 07:30AM
Nov-15-23 10:16AM
Nov-07-23 04:15PM
07:30AM Loading…
Nov-02-23 07:30AM
Nov-01-23 07:30AM
Oct-26-23 07:00AM
Oct-19-23 07:30AM
03:44AM
Oct-13-23 06:02PM
Oct-06-23 03:07PM
Sep-27-23 07:30AM
Sep-26-23 07:01AM
Sep-14-23 05:12PM
Sep-05-23 10:00AM
Aug-08-23 07:30AM
Aug-01-23 07:00AM
Jul-17-23 07:30AM
Jul-05-23 08:00AM
06:30AM Loading…
06:30AM
Jul-01-23 06:30AM
Jun-27-23 07:30AM
Jun-21-23 08:00PM
Jun-07-23 07:30AM
May-18-23 12:28PM
May-04-23 07:30AM
Apr-27-23 10:03AM
Apr-26-23 08:00PM
Apr-20-23 07:30AM
Apr-19-23 07:47AM
Mar-07-23 07:00AM
Mar-03-23 07:30AM
Feb-27-23 07:30AM
Feb-16-23 07:30AM
Feb-13-23 06:43AM
Feb-06-23 07:30AM
Jan-27-23 12:10PM
Jan-05-23 07:30AM
Dec-15-22 07:30AM
Dec-12-22 08:00AM
07:30AM
Nov-15-22 07:30AM
Nov-14-22 07:40AM
07:30AM
Nov-07-22 07:30AM
Nov-03-22 07:30AM
Oct-20-22 07:30AM
Sep-26-22 07:00AM
Aug-17-22 07:30AM
Aug-07-22 08:29AM
Aug-04-22 07:30AM
Jul-28-22 07:30AM
Jul-25-22 10:24AM
Jul-21-22 07:30AM
06:30AM
Jun-30-22 08:00AM
Jun-13-22 08:30AM
Jun-09-22 11:34AM
Jun-02-22 07:31AM
07:00AM
May-10-22 10:45AM
May-05-22 07:30AM
Apr-21-22 07:30AM
Apr-13-22 06:30AM
Apr-05-22 01:07PM
Mar-31-22 07:00AM
Mar-29-22 07:00AM
Mar-19-22 08:55AM
Mar-17-22 10:45AM
Mar-02-22 07:00AM
Mar-01-22 06:55AM
Feb-20-22 07:20AM
Feb-17-22 06:30AM
Feb-16-22 08:30AM
Feb-15-22 01:56PM
Feb-08-22 09:38AM
Feb-07-22 06:38PM
06:38PM
05:38PM
09:38AM
Feb-04-22 05:38PM
05:38PM
01:38PM
Feb-03-22 01:38PM
09:38AM
Feb-02-22 09:38AM
08:00AM
07:00AM
Feb-01-22 07:30AM
Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women's health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Weaver KirkeGen. Counsel & Corp. Secy.Feb 22Buy18.362,72049,93915,181Feb 23 11:46 AM
DiMarco KathrynCorporate ControllerFeb 09Option Exercise0.001,87109,388Feb 13 04:16 PM
WALSH MATTHEW MChief Financial OfficerMar 31Option Exercise0.007,753039,459Apr 04 08:21 PM
Weaver KirkeGen. Counsel & Corp. Secy.Mar 31Option Exercise0.007,419012,900Apr 04 08:21 PM
Stahler Rachel AChief Information OfficerMar 31Option Exercise0.003,578022,528Apr 04 08:20 PM
Morrissey Joseph T. Jr.Head of ManufacturingMar 31Option Exercise0.003,936018,636Apr 04 08:18 PM
Fiedler SusanneChief Commercial OfficerMar 31Option Exercise0.004,771022,166Apr 04 08:17 PM
Milligan SandraHead of Research & DevelopmentMar 31Option Exercise0.005,964026,825Apr 04 08:18 PM
Falcione AaronChief Human Resources OfficerMar 31Option Exercise0.003,578013,365Apr 04 08:15 PM
DiMarco KathrynCorporate ControllerMar 31Option Exercise0.004,29408,169Apr 04 08:14 PM
Ali KevinChief Executive OfficerMar 31Option Exercise0.0021,471051,390Apr 04 08:13 PM